Andreas Weigelt

Invenda Group AG is a Swiss-based software company that specializes in providing smart technologies to automate retail businesses. Invenda Group is based in Alpnach, CH. The company's focus is on transforming the automated retail industry through the use of innovative software solutions. The company was founded in 2017 by Jon Brezinski, who has been the CEO since its inception.

National Confectioners Association of The United States, Inc. is a non-profit organization that advances, protects and promotes chocolate, candy, gum and mints, and the companies that make these special treats. The company is headquartered in Washington, DC.

Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland.

Lindt & Sprungli SA manufactures and sells chocolates and candies. It offers cacao beans and confectionery products. The company was founded on May 16, 1967 and is headquartered in Paris, France.

Chocoladefabriken Lindt & Sprüngli (Schweiz) AG engages in the production and distribution of chocolate products. It offers its products under the brands Bâtons, CHOCOLETTI, CONNAISSEURS, DIVA, EXCELLENCE, GRAND PLAISIR, HAUCHDÜNN, Lindor, and Lindt Mini Pralinés. The company was founded on June 10, 1994 and is headquartered in Kilchberg, Switzerland.

Ghirardelli Chocolate Co. manufactures and markets chocolate products. Its products include chocolate bars, shakes, seasonal treats, baking chips, and cocoa powder. The company was founded by Domingo Ghirardelli in 1852 and is headquartered in San Leandro, CA

Russell Stover Candies, Inc. manufactures boxed chocolates. The company was founded in 1923 and is headquartered in Kansas City, MO.

Lindt & Sprüngli (Canada), Inc. operates as a chocolatier and confectionery company. It offers chocolates of different brands including lindor, excellence, swiss classic, and creation. The company is headquartered in Toronto, Canada.

zCapital AG (zCapital) is an independent Swiss asset management firm which was established in 2008. Based in Zug, the firm specializes in Swiss equities and manages the zCapital Swiss Small & Mid Cap Fund and the zCapital Swiss Dividend Fund. They are a socially responsible investor which donates a portion of the fees they earn to a range of charities.

Dynamics Group AG is an independent Swiss investment research firm which was founded by Franz Egle in 2006. Headquartered in Zurich, the firm offers comprehensive consulting services with a focus on?Corporate Communications, Capital Market Communication, Public Affairs as well as Reputation Management and Crisis Communication. Research and Analysis is supported by a team of 30 financial analysts and market researchers in India.

Founded in 1873, Siegfried AG is a chemical product manufacturing company. The company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG.

Obermatt AG operates as a financial research company that focusses on indexing company performance. It also offers indexed compensation and indexed strategy controlling services. The company was founded on August 24, 2001 and is headquartered in Zurich, Switzerland.

Arch Chemicals Ltd. engages in the manufacture of inorganic basic chemicals. Its products are mainly used in the swimming pool for body treatment. The company was founded on February 24, 1978 and is headquartered in Castleford, the United Kingdom.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Founded in 1966, Synthomer (UK) Ltd. is a subsidiary of Synthomer Plc. The company is based in Harlow, UK. Synthomer (UK specializes in creating emissions-reducing formulations that are used to make a wide range of products that are essential to modern life.

PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden.

Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India.

Deutsche Bank (Suisse) SA provides banking services and financial solutions to private and institutional clients. The firm specializes in providing wealth management and investment consulting services to private customers. It also offers asset management solutions to institutional clients. The company was founded in 1980 and is headquartered in Geneva, Switzerland.

Banque Lombard Odier & Cie. SA provides financial services. The firm specialized in asset and wealth management, institutional asset management, and private banking services. It has a network of 24 offices in 17 countries. The company was founded in 1796 and is headquartered in Geneva, Switzerland.

Part of DSM-Firmenich AG, DSM Nutritional Products AG is a Swiss purpose-led science-based company in nutrition, health, and bioscience. The private company is based in Kaiseraugst, Switzerland. The company provides solutions for animal nutrition, human nutrition & care, food & beverage, and materials. DSM's climate change agenda focuses on reducing their own carbon footprint, enabling the low-carbon economy with their solutions, and advocating climate action. The CEO of the company is Dimitri de Vreeze.

Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA.

Arcondis AG is the largest consulting Swiss company in Switzerland that exclusively specializes in the life sciences industry. The private company is based in Reinach, Switzerland. The company provides consulting services to clients in the healthcare and life science industries, with a focus on quality and regulatory aspects. Arcondis has expertise in compliance, business processes, information technology, and digital transformation and engagement.

Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow.

Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland.

University Children's Hospital Basel provides a large-scale biomedical database and research resource called UK Biobank. The private company is based in Basel, Switzerland. The database contains in-depth genetic and health information from half a million UK participants, which is regularly augmented with additional data. Approved researchers and scientists can access the database to undertake vital research into the most common and life-threatening diseases. UK Biobank has enabled several scientific discoveries that improve human health.